Why China is making hospitals offer women pain relief for childbirth
China has mandated that all tertiary hospitals (over 500 beds) must offer epidural anaesthesia during childbirth by the end of 2024, with plans to extend to secondary hospitals (over 100 beds) by 2027.
The initiative aims to create a more "friendly childbearing environment" amid declining birth rates in China.
Currently, only about 30% of pregnant women in China receive anesthesia for pain relief during childbirth, compared to over 70% in some developed countries.
The World Health Organisation recommends epidurals for healthy pregnant women, and they are widely used in countries like France, the United States, and Canada.
To encourage more women to have children, an increasing number of provinces in China are including childbirth anesthesia costs in medical insurance schemes, and some provinces are extending marriage and maternity leave.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
2 hours ago
- The Independent
This £12 K-beauty sunscreen uses rice to fight ageing – so I tested it for 9 months
If you're on the Korean skincare hype, then you'll likely have heard of Beauty of Joseon. Founded in 2016, the brand draws on the power of herbal ingredients; it's named for those used as medicine in the Joseon dynasty through the 14th to 19th centuries. This includes ginseng, green tea and – of course – rice. If you're sceptical about the anti-ageing benefits of Uncle Ben's, I spoke to dermatologists to find out if rice works, or if it's just marketing. Dr Simon Ourian, a dermatologist with clients including Kylie Jenner and Lady Gaga, says that rice has 'impressive anti-ageing benefits.' Dr Ourian explains that it 'delivers a natural plumping effect, making the skin appear more youthful and revitalised.' I also spoke to consultant dermatologist Dr Sina Ghadiri, who agrees and says, 'Rice-derived products can be a beneficial complement to an anti-ageing skincare routine.' However, Dr Ghadiri qualifies that rice isn't an all-encompassing solution to the signs of ageing; he adds that '[rice] shouldn't replace cornerstone ingredients like topical retinoids, vitamin C, or peptides.' That said, he finds that rice extract 'gives a soothing barrier-protective formula, making it especially suitable for those seeking both sun protection and skin-nourishing benefits.' So it's no surprise that Beauty of Joseon's rice-packed sunscreen is doing the rounds on social media, and I first got my hands on the bestseller in September 2024 when reviewing the best Korean skincare brands. I loved it from the off, but you can only really tell if anti-ageing products are worth the money after prolonged use. Nine months later, I've found out if this rice-based SPF actually works. How I tested SPF is important whether the sky's looking overcast or crystal clear, so I've been using my Beauty of Joseon relief sun cream for more than nine months. This included days when my car windscreen was frosted over and, more recently, as temperatures have been nearing the thirties. Following Dr Marko Lens' advice on how much SPF to apply, I used around one teaspoon's worth of the formula across my face and neck, and noted its consistency and finish on the skin. I paid attention to how quickly the cream absorbed and how it wore throughout the day, recording its sticking power and any instances of sunburn. With ginseng, green tea, rice and niacinamide included in the formula, I closely reviewed any positive or negative changes to my complexion as a result of continued use. Why you can trust IndyBest reviews Lucy Smith joined the IndyBest team in July 2020 and, since then, has covered everything from SPF moisturisers to Supergoop's mattescreen SPF. She's spoken to expert dermatologists about a variety of suncreen topics and has tested many of the industry's best formulas, from Garnier to The Ordinary.
The Independent
7 hours ago
- The Independent
Malaysia records first Covid death of 2025
Malaysia saw its first Covid death of 2025 earlier this month, health authorities said. The health ministry noted that this was the first Covid fatality since 26 May last year. The deceased had heart disease and diabetes and hadn't taken a second booster shot. 'This marks a significant decline compared to 57 Covid deaths reported in 2024, with the last fatality recorded on May 26 last year,' the ministry said in a statement on Thursday. From January to 15 June this year, Malaysia recorded 21,738 cumulative Covid cases, with the weekly average holding at about 900, The Rakyat Post reported. The ministry reported a sharp 68 per cent week-on-week increase with 3,379 cases from 8 to 15 June compared to 2,011 the week prior. Despite the rise, the ministry stressed the national situation remained stable and well below the alert threshold. At least six individuals with underlying health conditions had been admitted to ICU. 'All cases were closely monitored with care, with all patients discharged from the ICUs. Four were allowed to return home, with two transferred to normal wards,' the ministry said. The new Nimbus Covid strain (NB.1.8.1) is rapidly spreading around the world and is being closely monitored by the World Health Organisation. This strain is linked to a rise in infections in several parts of Asia, including India, Hong Kong, Thailand, and Singapore. First recognised in January 2025, NB.1.8.1, an omicron variant, is now the dominant variant in China and Hong Kong. It has also spread to the US and Australia. ' SARS-CoV-2 continues to evolve, and between January and May 2025, there were shifts in global SARS-CoV-2 variant dynamics,' a WHO spokesperson said earlier. 'At the beginning of the year, the most prevalent variant tracked by WHO at the global level was XEC, followed by KP.3.1.1. In February, circulation of XEC began to decline while that of LP.8.1 increased, with the latter becoming the most detected variant in mid-March. Since mid-April, the circulation of LP.8.1 has been slightly declining as NB.1.8.1 is increasingly being detected.' By late April, NB.1.8.1 comprised about 10.7 per cent of submitted sequences globally, according to the WHO, up from just 2.5 per cent a month before. The WHO has designated Nimbus as a Variant Under Monitoring. Preliminary data suggests that Nimbus spreads more rapidly than earlier variants. Reported symptoms commonly include a sharp, razor-like sore throat, fatigue, mild cough, fever, muscle aches, and nasal congestion. However, the public health risk posed by this variant is evaluated as low at the global level. 'Despite a concurrent increase in cases and hospitalisations in some countries where NB.1.8.1 is widespread, current data don't indicate that this variant leads to more severe illness than other variants in circulation,' the WHO said. Although it may not be particularly severe, Nimbus may infect people more easily than earlier variants. There's some evidence that the variant binds more tightly to human cells. The ministry of health urged all Malaysians to stay protected by adhering to the recommended vaccination schedules outlined in the National Immunisation Programme.
The Sun
9 hours ago
- The Sun
The strange sign in your EARWAX that can predict if you'll develop devastating brain disorder
Eliza Loukou, Health Reporter Published: Invalid Date, YOUR earwax could be used to predict whether you'll develop Parkinson's, scientists say, About 153,000 people in the UK live with the devastating neurological disorder, caused by a loss of nerve cells in the brain. The progressive disease is characterised by symptoms such as tremors, slow movement and muscle stiffness, which slowly get worse. According to researchers Zhejiang University in China, most Parkinson's treatments only slow the disease's progression, so early diagnosis is important for managing symptoms. But current tests for spotting the disease - such as brain scans or rating scales - can be expensive or subjective, they said. Now, a study published to Analytical Chemistry suggests that earwax could be used as a cost effective way to screen people for Parkinson's. Researchers claimed they'd developed a new AI system that could help catch the disease at an early stage, using earwax samples. Previous studies have shown that changes in sebum - an oily substance secreted by the skin - could help identify people with Parkinson's. Sebum from people with the disease may have a characteristic, musky smell because volatile organic compounds released by sebum are altered by disease progression. But sebum on the surface of the skin isn't a reliable substance for testing as it's exposed to pollution or humidity, which can change its composition. However, sebum in ear canals is sheltered from the elements. Seeing as the oily substance is the main component of earwax and it's easy to sample, researchers decided to use it for their screening tool. Good Morning Britain star reveals Parkinson's diagnosis after tragic death of his wife To identify the compounds released by sebum in people with Parkinson's, the researchers swabbed the ear canals of 209 participants, more than half of which were diagnosed with the condition. They then analysed wax samples, identifying four volatile organic compounds specific to people with Parkinson's. Those include ethylbenzene, 4-ethyltoluene, pentanal, and 2-pentadecyl-1,3-dioxolane. Researchers said these could serve as potential biomarkers for Parkinson's. Using these findings, they were able to develop a system that inexpensively screens for Parkinson's. Everything you need to know about Parkinson's Parkinson's is a progressive neurological condition, meaning that it causes problems in the brain and gets worse over time. It affects around 153,000 people in the UK. People with Parkinson's don't have enough of the chemical dopamine because some of the nerve cells that make it have stopped working. This can cause a range of more than 40 symptoms, but the three main ones are: Tremor (shaking) Slow movement Rigidity (muscle stiffness) Other common signs include: Mild memory and thinking problems Trouble sleeping Issues with balance Pain Anxiety and depression Shuffling walk with very small steps Difficulty making facial expressions Loss of sense of smell Problems peeing Constipation The four main ways of managing Parkinson's include medication, staying active, exploring occupational therapy, physical therapy and speech and language therapy, and monitoring symptoms. They trained an artificial intelligence olfactory system - a robotic model that can mimic how we smell - with their ear wax compound data. They found it was able to categorise samples with and without Parkinson's with 94 percent accuracy. Researchers suggested their system could be used to a first-line screening tool for early Parkinson's detection and could help improve care for condition by making it possible to administer treatments earlier. Author Hao Dong said: 'This method is a small-scale single-center experiment in China." 2 'The next step is to conduct further research at different stages of the disease, in multiple research centres and among multiple ethnic groups, in order to determine whether this method has greater practical application value.' Earlier this year, scientists warned of a surge in cases of Parkinson's. They said 25 million people across the world will be living with the debilitating brain condition by 2050.
